At
Athenex
Buffalo NYFounded 2002500 employees
Private CapbiotechAcquiredOncology
Platform: Src Kinase
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mavucagene | ATH-4755 | Phase 1/2 | 1 | VEGF | RettRB | ||
| ATH-6254 | ATH-6254 | Approved | 4 | FGFR | PsA | ||
| Zorinaritide | ATH-9344 | NDA/BLA | 1 | PSMA | Wet AMDPancreatic Ca | ||
| Talabrutinib | ATH-1101 | Phase 1/2 | 1 | GPRC5D | HNSCCFL |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (7)